LSV Asset Management’s Medifast MED Stock Holding History

LSV Asset Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,700	Closed	-$109K	–	846
2024 Q3	$109K	Hold	5,700	–	–	﹤0.01%	792
2024 Q2	$124K	Sell	5,700 -2,400	-30%	-$64K	﹤0.01%	814
2024 Q1	$310K	Hold	8,100	–	–	﹤0.01%	773
2023 Q4	$544K	Sell	8,100 -800	-9%	-$55.7K	﹤0.01%	726
2023 Q3	$666K	Hold	8,900	–	–	﹤0.01%	714
2023 Q2	$820K	Hold	8,900	–	–	﹤0.01%	715
2023 Q1	$923K	Hold	8,900	–	–	﹤0.01%	672
2022 Q4	$1.03M	Buy	8,900 +6,400	+256%	+$745K	﹤0.01%	652
2022 Q3	$271K	Buy	2,500 +1,700	+213%	+$244K	﹤0.01%	768
2022 Q2	$144K	Buy	+800	New	+$143K	﹤0.01%	831
2017 Q4	–	Sell	-50,600	Closed	-$3M	–	997
2017 Q3	$3M	Sell	50,600 -41,400	-45%	-$2.06M	0.01%	668
2017 Q2	$3.81M	Buy	92,000 +18,934	+26%	+$823K	0.01%	609
2017 Q1	$3.24M	Buy	73,066 +51,266	+235%	+$2.21M	0.01%	637
2016 Q4	$907K	Sell	21,800 -1,545	-7%	-$62.2K	﹤0.01%	811
2016 Q3	$882K	Sell	23,345 -3,855	-14%	-$138K	﹤0.01%	793
2016 Q2	$904K	Sell	27,200 -12,500	-31%	-$403K	﹤0.01%	785
2016 Q1	$1.2M	Sell	39,700 -3,200	-7%	-$93.5K	﹤0.01%	724
2015 Q4	$1.3M	Hold	42,900	–	–	﹤0.01%	712
2015 Q3	$1.15M	Hold	42,900	–	–	﹤0.01%	702
2015 Q2	$1.39M	Hold	42,900	–	–	﹤0.01%	680
2015 Q1	$1.28M	Buy	+42,900	New	+$1.36M	﹤0.01%	666

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

LSV Asset Management's MED Position: Q4 2024 in Review

LSV Asset Management sold out of Medifast (MED) in Q4 2024, closing a stake of 5,700 shares — an estimated $109K sold.

LSV Asset Management first reported a position in MED in Q1 2015 and held it in 21 quarters. The position peaked at $3.81M in Q2 2017. 129 funds tracked by Wall St. Rank hold MED as of Q4 2024.

LSV Asset Management reported no remaining Medifast position as of Q4 2024 after selling out during the quarter.
LSV Asset Management sold 5,700 Medifast shares in Q4 2024, an estimated $109K.
LSV Asset Management first reported a position in Medifast in Q1 2015 and held it in 21 quarters.
LSV Asset Management's Medifast position peaked at $3.81M in Q2 2017.
129 funds tracked by Wall St. Rank held Medifast as of Q4 2024.

Based on LSV Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.